🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-12-12
Trial ID
NCT00279019
Treatments Being Tested
Salt Bridging study for GSK961081...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-29
Trial ID
NCT00550225
Treatments Being Tested
This is a multicenter, randomized, double-blind, double-dummy, parallel gro...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-04-04
Trial ID
NCT01822899
This study investigated the effect of exercise and high-dose salbutamol on ...
Status
Completed
Location
Novartis Investigative site
Start Date
2007-08
Trial ID
NCT00531050
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of GSK2269557 adminis...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-03-31
Trial ID
NCT02294734
Treatments Being Tested
Even patients with milder COPD can have significant physiological abnormali...
Status
Completed
Location
Respiratory Investigation Unit at Kingston General Hospital
Start Date
2007-12
Trial ID
NCT00559312
Treatments Being Tested
This study is a multi-centre, randomised, double-blind, placebo-controlled ...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-10-01
Trial ID
NCT02567708
Treatments Being Tested
The Fluticasone Propionate/Salmeterol combination (FSC) at a dose of 100/50...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02218762
Study will investigate the pharmacodynamics of a dual pharmacophore in whic...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-03-10
Trial ID
NCT00687700
Treatments Being Tested
GW685698X is a novel glucocorticoid receptor agonist that is being develope...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-15
Trial ID
NCT00522678